These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34189590)

  • 1. [Systemic treatment of moderate/severe hidradenitis suppurativa].
    Pinter A; Mrowietz U; Volz T
    Hautarzt; 2021 Aug; 72(8):686-691. PubMed ID: 34189590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of acne inversa].
    Schneider-Burrus S; Arpa E; Kors C; Stavermann T; Sabat R; Kokolakis G
    Hautarzt; 2018 Jan; 69(1):58-63. PubMed ID: 29234829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review.
    Blok JL; van Hattem S; Jonkman MF; Horváth B
    Br J Dermatol; 2013 Feb; 168(2):243-52. PubMed ID: 23106519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Medical Treatment Options for Hidradenitis Suppurativa.
    Deckers IE; Prens EP
    Drugs; 2016 Feb; 76(2):215-29. PubMed ID: 26659474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with hidradenitis suppurativa.
    Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy.
    Vural S; Gündoğdu M; Akay BN; Boyvat A; Erdem C; Koçyiğit P; Bostancı S; Sanli H; Kundakci N
    Dermatol Ther; 2019 Sep; 32(5):e13003. PubMed ID: 31237104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA: FOCUS ON ALTERNATIVES.
    Tchernev G
    Georgian Med News; 2023; (340-341):297-300. PubMed ID: 37805915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis Suppurativa: Rapid Evidence Review.
    Wipperman J; Bragg DA; Litzner B
    Am Fam Physician; 2019 Nov; 100(9):562-569. PubMed ID: 31674740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
    Aarts P; van Huijstee JC; van der Zee HH; van Straalen KR; Prens EP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):904-909. PubMed ID: 38112226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.
    Jemec GBE; Okun MM; Forman SB; Gulliver WPF; Prens EP; Mrowietz U; Armstrong AW; Geng Z; Gu Y; Williams DA; Teixeira HD; Kimball AB
    Br J Dermatol; 2019 Nov; 181(5):967-975. PubMed ID: 30916379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
    Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
    J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis Suppurativa: Review of the Pathogenesis and Treatment.
    Kurayev A; Ashkar H; Saraiya A; Gottlieb AB
    J Drugs Dermatol; 2016 Aug; 15(8):1017-22. PubMed ID: 27538005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
    Scheinfeld N
    Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients.
    McPhie ML; Bridgman AC; Kirchhof MG
    J Cutan Med Surg; 2019; 23(3):270-276. PubMed ID: 30658534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.